series-c-plus
Stage
1
Investors
About
MeMed Diagnostics Ltd develops diagnostic platforms combining molecular and cellular immunology with bioinformatics and big data analysis to improve management of infectious diseases and inflammatory disorders, including an FDA-approved test that differentiates viral from bacterial infections.
Explore MeMed Diagnostics Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.